Stage III Gastric Cancer: Alina's Survivor Story

Patient Info: Alina | Stage III

Alina completed treatment and reported being in remission, with regular checkups to watch for recurrence.

Our Cancer StoriesRead more →

Stage I Gastric Cancer: Allen's Patient Story

Patient Info: Allen Wang, Male | Stage I

After surgery, all 24 removed lymph nodes were cancer-free. Allen recovered quickly, returned to work, and was doing well at follow-up.

Memorial Sloan KetteringRead more →

Gastric Cancer: Christopher's Survivor Story

Patient Info: Christopher Lynch, Male, 50s | Stage Metastatic/Advanced

Metastatic Site: brain

By the latest update, he had no evidence of disease from January 2018 and had been in remission for 18 months.

Memorial Sloan KetteringRead more →

Durable complete remission after brain metastases from gastric cancer

Patient Info: Anonymized, Male, 50s | Stage IV

Biomarkers: HER2-low, PD-L1 CPS 5

Metastatic Site: brain

By July 2024 the brain lesions had completely resolved, and complete remission remained sustained through October 2025, with more than 38 months off anticancer treatment.

PubMed CentralRead more →

Hereditary diffuse gastric cancer with a CDH1 mutation and a separate gallbladder cancer

Patient Info: Anonymized, female, 60s | Stage I

Biomarkers: Pathogenic germline CDH1 mutation

A 67-year-old woman with multiple small signet-ring gastric cancers underwent total gastrectomy and was found to carry a pathogenic germline CDH1 mutation.

PubMed CentralRead more →

Complete response to chemotherapy and immunotherapy in Stage IV gastric cancer

Patient Info: Anonymized, Male, 70+ | Stage IV

Biomarkers: PD-L1 CPS 75

He achieved a complete radiologic and metabolic response and remained clinically well with no evidence of recurrence at follow-up in March 2026 while continuing nivolumab.

PubMed CentralRead more →

Stage IV Gastric Cancer: Derek's Patient Story

Patient Info: Derek Cooney | Stage IV

After a Stage IV stomach cancer diagnosis, an emergency physician sought several second opinions and enrolled in a clinical trial at UT MD Anderson.

MD AndersonRead more →

Stage IV Gastric Adenocarcinoma: Derek's Survivor Story

Patient Info: Derek Cooney, Male, 40s | Stage IV

Metastatic Site: peritoneum

At his first follow-up in June, scans showed no evidence of disease, and he later completed his pain-management fellowship.

MD AndersonRead more →

Gastric cancer surgery after chemotherapy with careful preservation of a liver artery

Patient Info: Anonymized, Male, 50s

He recovered without surgical complications and was discharged in stable condition on postoperative day 9.

PubMed CentralRead more →

Gastric cancer treatment during hemodialysis after liver recurrence

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: HER2-negative

Metastatic Site: liver|peritoneum

The cancer progressed in the peritoneum despite treatment, and systemic therapy was stopped in August 2024 before transfer to hospice in October 2024.

PubMed CentralRead more →

Gastric cancer surgery and adjuvant treatment followed by endocrine complications

Patient Info: Anonymized, Female, 40s

After cancer treatment, she was hospitalized with severe nutritional and endocrine complications and improved with hormone replacement and nutritional support.

PubMed CentralRead more →

Stage IV AFP-producing gastric cancer responds to chemotherapy and immunotherapy

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: HER2-negative; pMMR; elevated AFP

Metastatic Site: liver|peritoneum

Imaging showed a sustained partial response, his AFP level returned to normal, and he continued maintenance serplulimab at the latest follow-up.

PubMed CentralRead more →

Cancer-free after gastric surgery before a spontaneous twin pregnancy

Patient Info: Anonymized, Female, Under 40

She was described as cancer-free after gastrectomy before conceiving twins in 2024.

PubMed CentralRead more →

Hereditary diffuse gastric cancer managed with repeated endoscopic treatment and gastrectomy

Patient Info: Anonymized, Male, 40s

Biomarkers: CDH1 mutation

Two years after total gastrectomy, he remained free of recurrence.

PubMed CentralRead more →

Severe vitamin B12 deficiency 8 years after gastrectomy for gastric cancer

Patient Info: Anonymized, Male, 40s

A 49-year-old man developed severe neurologic problems from vitamin B12 deficiency 8 years after total gastrectomy for gastric cancer.

PubMed CentralRead more →

Metastatic Signet Ring Cell Stomach Cancer With Ménétrier’s Disease

Patient Info: Anonymized, Female | Stage Metastatic/Advanced

Metastatic Site: peritoneum|omentum

She was living with metastatic gastric signet ring cell carcinoma involving the peritoneum and received palliative chemotherapy.

PubMed CentralRead more →

Severe skin reaction after immunotherapy for metastatic gastric cancer

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: pMMR; PD-L1 CPS ~10; HER2 1+

Metastatic Site: liver

He recovered from the severe treatment-related skin reaction and was discharged after 32 days, with sintilimab permanently discontinued.

PubMed CentralRead more →

Complete response in Stage IV gastric cancer after chemotherapy, immunotherapy, and surgery

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: HER2-negative; MSS; PD-L1 high

Metastatic Site: liver

He achieved a complete pathologic response and remained free of recurrence for 3 years and 3 months after surgery.

PubMed CentralRead more →

Recovery from severe liver injury during Stage III gastric cancer treatment

Patient Info: Anonymized, Male, 70+ | Stage III

At the last follow-up in August 2025, imaging showed no recurrence and his liver function remained normal.

PubMed CentralRead more →

Stage IV gastric cancer with benign breast hemangioma during ramucirumab therapy

Patient Info: Anonymized, Female, Under 40 | Stage IV

Biomarkers: Gastric cancer: HER2 negative, PD-L1 TPS >=5%

Metastatic Site: peritoneum; preaortic lymph nodes; omentum

After initial response to FOLFOX/nivolumab and temporary benefit from paclitaxel/ramucirumab and FOLFIRI, the gastric cancer progressed to massive ascites. Trifluridine/tipiracil was attempted, but she died from rapid disease progression.

PubMed CentralRead more →

Early Stomach Cancer Surgery Followed by a Rare Bowel Complication

Patient Info: Anonymized, Female, 70+ | Stage I

At 6 months after corrective surgery, she remained free of vomiting without symptom recurrence.

PubMed CentralRead more →

Stage IV HER2-Positive Gastric Cancer With Immune Thrombocytopenia During Treatment

Patient Info: Anonymized | Stage IV

Biomarkers: HER2 amplified; PD-L1 CPS 10; pMMR; Claudin18.2 overexpression

Metastatic Site: liver, omentum

CT in March 2024 showed progression with enlarging gastric and omental lymphadenopathy and new liver metastases.

PubMed CentralRead more →

Metastatic Gastric Cancer Treatment Complicated by Recurrent Cytokine Release Syndrome

Patient Info: Anonymized, female, 70+ | Stage IV

Metastatic Site: peritoneum, bone

She had a partial response after 6 cycles but later chose to stop chemotherapy because treatment toxicity and declining health were affecting quality of life.

PubMed CentralRead more →

ALK-Fusion Gastric Cancer Responds to Alectinib Before Progression

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: DCTN1–ALK fusion; ATM p.E1724*; CDK6 amplification; HER2 negative; mismatch-repair proteins intact; later KRAS amplification

Metastatic Site: bone

Alectinib produced a partial response for about 11.5 months, but the cancer later progressed systemically and she died from uncontrollable gastrointestinal bleeding.

PubMed CentralRead more →